Nelfinavir Mesylate

Form: Tablet & Oral Powder

Strength: Tablets: 250 mg, 625 mg: Oral Powder: 50 mg/g

Reference Brands: Viracept®

Category: Anti Viral

Nelfinavir Mesylate Tablets, marketed under the brand Viracept®, are antiretroviral medications classified as protease inhibitors used in the treatment of HIV-1 infection. Each tablet typically contains 250 mg or 625 mg of Nelfinavir. Though less commonly prescribed today due to newer agents, Nelfinavir remains essential in select HIV programs and resource-limited settings. On PharmaB2B platforms, global buyers can source WHO-GMP or USFDA-compliant formulations from certified manufacturers and exporters. Ideal for tenders, NGO procurement, and specialty HIV care, Nelfinavir supports access to alternative HIV treatment options. Connect with reliable suppliers to ensure quality-assured antiretroviral availability.